When food reaches your intestine, it triggers the release of hormones that signal to other parts of your body
Consumers are gravitating towards brands that emphasise science-backed formulations, as seen in Sebameds focus on pH balance and Byomas barrier-boosting ingredients
Oral GLP-1 RAs have been introduced to improve convenience, although their weight-loss efficacy is generally lower and gastrointestinal adverse effects tend to be more pronounced than with injectable formulations [39, 40]
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), may indirectly affect menstrual cycles in some women
In addition, GLP-1RAs have been shown to affect osteoclasts, stimulating their differentiation, but reducing the resorbed area (37), and reducing SOST/sclerostin expression in osteocyte-like MLO-Y4 cells (39)
, Eli Lilly